Clinical vaccine efficacy and clinical effectiveness of oseltamivir in reducing Influenza related complications in patients with a solid organ transplant (inFLUenza in Solid Organ Transplant recipients, FLUSOT)
- Conditions
- respiratory virus infection in solid organ transplant recipients
- Registration Number
- NL-OMON21725
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
Admission in a hospital within the Leiden Transplantation Region with laboratory confirmed Influenza A or B infection or with a diagnostic test for respiratory virus infection in solid organ recipient (kidney, liver, pancreas or combination) between October 2013 and March 2020 (end of flu season 2020)
Exclusion Criteria
none
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 30 day mortality
- Secondary Outcome Measures
Name Time Method ICU admission<br>clinical vaccine effectiveness